KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Pacific Biosciences Of California (PACB) over the last 17 years, with Q3 2025 value amounting to $54.8 million.

  • Pacific Biosciences Of California's Operating Expenses fell 2605.66% to $54.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $705.0 million, marking a year-over-year increase of 5819.56%. This contributed to the annual value of $511.6 million for FY2024, which is 3211.08% up from last year.
  • Latest data reveals that Pacific Biosciences Of California reported Operating Expenses of $54.8 million as of Q3 2025, which was down 2605.66% from $59.5 million recorded in Q2 2025.
  • Over the past 5 years, Pacific Biosciences Of California's Operating Expenses peaked at $427.6 million during Q1 2025, and registered a low of $46.7 million during Q1 2021.
  • Over the past 5 years, Pacific Biosciences Of California's median Operating Expenses value was $89.8 million (recorded in 2021), while the average stood at $108.7 million.
  • Over the last 5 years, Pacific Biosciences Of California's Operating Expenses had its largest YoY gain of 36151.18% in 2025, and its largest YoY loss of 6724.85% in 2025.
  • Over the past 5 years, Pacific Biosciences Of California's Operating Expenses (Quarter) stood at $81.4 million in 2021, then increased by 13.24% to $92.2 million in 2022, then grew by 5.31% to $97.1 million in 2023, then soared by 67.92% to $163.1 million in 2024, then tumbled by 66.41% to $54.8 million in 2025.
  • Its Operating Expenses stands at $54.8 million for Q3 2025, versus $59.5 million for Q2 2025 and $427.6 million for Q1 2025.